IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v13y2022i1d10.1038_s41467-022-30794-7.html
   My bibliography  Save this article

RNF43 G659fs is an oncogenic colorectal cancer mutation and sensitizes tumor cells to PI3K/mTOR inhibition

Author

Listed:
  • Lishan Fang

    (Harvard Medical School
    Broad Institute of MIT and Harvard
    Sun Yat-sen University)

  • Dane Ford-Roshon

    (Harvard Medical School
    Broad Institute of MIT and Harvard)

  • Max Russo

    (Harvard Medical School
    Broad Institute of MIT and Harvard)

  • Casey O’Brien

    (Harvard Medical School
    Broad Institute of MIT and Harvard)

  • Xiaozhe Xiong

    (Boston Children’s Hospital
    Blavatnik Institute, Harvard Medical School)

  • Carino Gurjao

    (Harvard Medical School
    Broad Institute of MIT and Harvard)

  • Maximilien Grandclaudon

    (Harvard Medical School
    Broad Institute of MIT and Harvard)

  • Srivatsan Raghavan

    (Harvard Medical School
    Broad Institute of MIT and Harvard)

  • Steven M. Corsello

    (Harvard Medical School
    Broad Institute of MIT and Harvard)

  • Steven A. Carr

    (Broad Institute of MIT and Harvard)

  • Namrata D. Udeshi

    (Broad Institute of MIT and Harvard)

  • James Berstler

    (Broad Institute of MIT and Harvard)

  • Ewa Sicinska

    (Harvard Medical School)

  • Kimmie Ng

    (Harvard Medical School)

  • Marios Giannakis

    (Harvard Medical School
    Broad Institute of MIT and Harvard)

Abstract

The RNF43_p.G659fs mutation occurs frequently in colorectal cancer, but its function remains poorly understood and there are no specific therapies directed against this alteration. In this study, we find that RNF43_p.G659fs promotes cell growth independent of Wnt signaling. We perform a drug repurposing library screen and discover that cells with RNF43_p.G659 mutations are selectively killed by inhibition of PI3K signaling. PI3K/mTOR inhibitors yield promising antitumor activity in RNF43659mut isogenic cell lines and xenograft models, as well as in patient-derived organoids harboring RNF43_p.G659fs mutations. We find that RNF43659mut binds p85 leading to increased PI3K signaling through p85 ubiquitination and degradation. Additionally, RNA-sequencing of RNF43659mut isogenic cells reveals decreased interferon response gene expression, that is reversed by PI3K/mTOR inhibition, suggesting that RNF43659mut may alter tumor immunity. Our findings suggest a therapeutic application for PI3K/mTOR inhibitors in treating RNF43_p.G659fs mutant cancers.

Suggested Citation

  • Lishan Fang & Dane Ford-Roshon & Max Russo & Casey O’Brien & Xiaozhe Xiong & Carino Gurjao & Maximilien Grandclaudon & Srivatsan Raghavan & Steven M. Corsello & Steven A. Carr & Namrata D. Udeshi & Ja, 2022. "RNF43 G659fs is an oncogenic colorectal cancer mutation and sensitizes tumor cells to PI3K/mTOR inhibition," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    • Handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-30794-7
    DOI: 10.1038/s41467-022-30794-7
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-022-30794-7
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-022-30794-7?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Bon-Kyoung Koo & Maureen Spit & Ingrid Jordens & Teck Y. Low & Daniel E. Stange & Marc van de Wetering & Johan H. van Es & Shabaz Mohammed & Albert J. R. Heck & Madelon M. Maurice & Hans Clevers, 2012. "Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors," Nature, Nature, vol. 488(7413), pages 665-669, August.
    2. Huai-Xiang Hao & Yang Xie & Yue Zhang & Olga Charlat & Emma Oster & Monika Avello & Hong Lei & Craig Mickanin & Dong Liu & Heinz Ruffner & Xiaohong Mao & Qicheng Ma & Raffaella Zamponi & Tewis Bouwmee, 2012. "ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner," Nature, Nature, vol. 485(7397), pages 195-200, May.
    3. Xiangbo Meng & Xiwei Liu & Xingdong Guo & Shutan Jiang & Tingting Chen & Zhiqiang Hu & Haifeng Liu & Yibing Bai & Manman Xue & Ronggui Hu & Shao-cong Sun & Xiaolong Liu & Penghui Zhou & Xiaowu Huang &, 2018. "FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells," Nature, Nature, vol. 564(7734), pages 130-135, December.
    4. Rehan Akbani & Patrick Kwok Shing Ng & Henrica M. J. Werner & Maria Shahmoradgoli & Fan Zhang & Zhenlin Ju & Wenbin Liu & Ji-Yeon Yang & Kosuke Yoshihara & Jun Li & Shiyun Ling & Elena G. Seviour & Pr, 2014. "A pan-cancer proteomic perspective on The Cancer Genome Atlas," Nature Communications, Nature, vol. 5(1), pages 1-15, September.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Victoria H. Ng & Zachary Spencer & Leif R. Neitzel & Anmada Nayak & Matthew A. Loberg & Chen Shen & Sara N. Kassel & Heather K. Kroh & Zhenyi An & Christin C. Anthony & Jamal M. Bryant & Amanda Lawson, 2023. "The USP46 complex deubiquitylates LRP6 to promote Wnt/β-catenin signaling," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    2. Xiangling Xiao & Jie Shi & Chuan He & Xia Bu & Yishuang Sun & Minling Gao & Bolin Xiang & Wenjun Xiong & Panpan Dai & Qi Mao & Xixin Xing & Yingmeng Yao & Haisheng Yu & Gaoshan Xu & Siqi Li & Yan Ren , 2023. "ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy," Nature Communications, Nature, vol. 14(1), pages 1-19, December.
    3. Yiqun Zhang & Fengju Chen & Darshan S. Chandrashekar & Sooryanarayana Varambally & Chad J. Creighton, 2022. "Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways," Nature Communications, Nature, vol. 13(1), pages 1-19, December.
    4. Christina M. Termini & Amara Pang & Tiancheng Fang & Martina Roos & Vivian Y. Chang & Yurun Zhang & Nicollette J. Setiawan & Lia Signaevskaia & Michelle Li & Mindy M. Kim & Orel Tabibi & Paulina K. Li, 2021. "Neuropilin 1 regulates bone marrow vascular regeneration and hematopoietic reconstitution," Nature Communications, Nature, vol. 12(1), pages 1-17, December.
    5. Sophie A. Herbst & Mattias Vesterlund & Alexander J. Helmboldt & Rozbeh Jafari & Ioannis Siavelis & Matthias Stahl & Eva C. Schitter & Nora Liebers & Berit J. Brinkmann & Felix Czernilofsky & Tobias R, 2022. "Proteogenomics refines the molecular classification of chronic lymphocytic leukemia," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
    6. Fengju Chen & Yiqun Zhang & Darshan S. Chandrashekar & Sooryanarayana Varambally & Chad J. Creighton, 2023. "Global impact of somatic structural variation on the cancer proteome," Nature Communications, Nature, vol. 14(1), pages 1-19, December.
    7. Jong Hoon Won & Jacob S. Choi & Joon-Il Jun, 2022. "CCN1 interacts with integrins to regulate intestinal stem cell proliferation and differentiation," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    8. María Bueno Álvez & Fredrik Edfors & Kalle Feilitzen & Martin Zwahlen & Adil Mardinoglu & Per-Henrik Edqvist & Tobias Sjöblom & Emma Lundin & Natallia Rameika & Gunilla Enblad & Henrik Lindman & Marti, 2023. "Next generation pan-cancer blood proteome profiling using proximity extension assay," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    9. Zachary T. Spencer & Victoria H. Ng & Hassina Benchabane & Ghalia Saad Siddiqui & Deepesh Duwadi & Ben Maines & Jamal M. Bryant & Anna Schwarzkopf & Kai Yuan & Sara N. Kassel & Anant Mishra & Ashley P, 2023. "The USP46 deubiquitylase complex increases Wingless/Wnt signaling strength by stabilizing Arrow/LRP6," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    10. Masashi Fujita & Mei-Ju May Chen & Doris Rieko Siwak & Shota Sasagawa & Ayako Oosawa-Tatsuguchi & Koji Arihiro & Atsushi Ono & Ryoichi Miura & Kazuhiro Maejima & Hiroshi Aikata & Masaki Ueno & Shinya , 2022. "Proteo-genomic characterization of virus-associated liver cancers reveals potential subtypes and therapeutic targets," Nature Communications, Nature, vol. 13(1), pages 1-11, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-30794-7. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.